Exploring the mechanism of dihydromyricetin in alleviating psoriasis based on metabolomics, network pharmacology and experimental validation
- 14 January 2026
- journal article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 360, 121167
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Liaoning Province (2023-MS-200)
- Shenyang Pharmaceutical University
- National Natural Science Foundation of China (81903789)
This publication has 49 references indexed in Scilit:
- Dihydromyricetin ameliorates experimental ulcerative colitis by inhibiting neutrophil extracellular traps formation via the HIF-1α/VEGFA signaling pathwayInternational Immunopharmacology, 2024
- Tryptophan catabolism via the kynurenine pathway regulates infection and inflammation: from mechanisms to biomarkers and therapiesInflammation Research, 2024
- Germacrone mitigates cardiac remodeling by regulating PI3K/AKT-mediated oxidative stress, inflammation, and apoptosisInternational Immunopharmacology, 2023
- Tryptophan metabolism in health and diseaseCell Metabolism, 2023
- Current and Future Therapies for Psoriasis with a Focus on Serotonergic DrugsMolecular Neurobiology, 2020
- Aryl Hydrocarbon Receptor Promotes Liver Polyploidization and Inhibits PI3K, ERK, and Wnt/β-Catenin SignalingiScience, 2018
- Glabridin, an isoflavan from licorice root, ameliorates imiquimod-induced psoriasis-like inflammation of BALB/c miceInternational Immunopharmacology, 2018
- Microbiota-Derived Indole Metabolites Promote Human and Murine Intestinal Homeostasis through Regulation of Interleukin-10 ReceptorThe American Journal of Pathology, 2018
- Dihydromyricetin suppresses inflammatory responsesin vitroandin vivothrough inhibition of IKKβ activity in macrophagesScanning, 2016
- Optimisation of the solvent extraction of bioactive compounds from Parkia speciosa pod using response surface methodologyFood Chemistry, 2011